UTZ-28530-80826
2 vaccinations
2 coded responses
26 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 770 / TX
- Registered
- 2021-03-08
- Relationship
- Self
- Race
- N/A
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-08
Registered in v-safe
-
2021-03-08
Dose 1 — Janssen/Johnson & Johnson
- 2021-03-08
- 2021-03-09
- 2021-03-11
- 2021-03-12
- 2021-03-13
- 2021-03-15
- 2021-03-25
- 2021-03-29
- 2021-04-05
- 2021-04-12
- 2021-04-19
- 2021-06-07
- 2021-09-08
-
2021-11-01
Dose 2 — Moderna
- 2021-11-01
-
2021-11-02
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain, Redness, Swelling · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2021-11-03
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain, Redness · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Vomiting, Diarrhea · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2021-11-04
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Headache, Fatigue or tirednessAdult check-in
-
2021-11-05
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-11-06
- 2021-11-08
- 2021-11-17
- 2021-11-22
- 2021-12-06
- 2021-12-13
-
2022-05-02
Survey response — 6 months, dose 2MedDRA: Cerebrovascular accident — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, HospitalizationFree text: StrokeMedDRA releases: 2024-11 · check-in free text available
-
2022-05-02
Report sent to call center — 6 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prEmergency room or emergency department visit · Hospitalization · 1 call case(s)
- 2022-05-03
-
2022-11-01
Survey response — 12 months, dose 2MedDRA: Rash — Feeling: GoodFree text: RashMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-08 | Janssen/Johnson & Johnson | |
| 2 | 2021-11-01 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-05-02 | Unsuccessful |
Free text
Release 11 — 6 months, dose 2
Symptoms: Stroke
Release 12 — 12 months, dose 2
Symptoms: Rash
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cerebrovascular accident | · | · | ✓ |
| SD | Rash | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release